Found: 6
Select item for more details and to access through your institution.
Contemporary HIV-1 consensus Env with AI-assisted redesigned hypervariable loops promote antibody binding.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-48139-x
- By:
- Publication type:
- Article
Diverse array of neutralizing antibodies elicited upon Spike Ferritin Nanoparticle vaccination in rhesus macaques.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-023-44265-0
- By:
- Publication type:
- Article
A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 632, p. 1, doi. 10.1126/scitranslmed.abi5735
- By:
- Publication type:
- Article
A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challenge.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00392-7
- By:
- Publication type:
- Article
A Trispecific Anti-HIV Chimeric Antigen Receptor Containing the CCR5 N-Terminal Region.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2020, v. 10, p. 1, doi. 10.3389/fcimb.2020.00242
- By:
- Publication type:
- Article
Simian Immunodeficiency Virus (SIV)-Specific Chimeric Antigen Receptor-T Cells Engineered to Target B Cell Follicles and Suppress SIV Replication.
- Published in:
- Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2018.00492
- By:
- Publication type:
- Article